ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $129 | -0.8% | 26,964 | +57.1% | 0.00% | – |
Q2 2023 | $130 | +85.7% | 17,168 | +10.4% | 0.00% | – |
Q1 2023 | $70 | -46.2% | 15,547 | +34.9% | 0.00% | – |
Q4 2022 | $130 | -99.8% | 11,528 | +72.7% | 0.00% | – |
Q3 2022 | $64,000 | +88.2% | 6,677 | +58.5% | 0.00% | – |
Q2 2022 | $34,000 | -57.5% | 4,213 | -10.5% | 0.00% | – |
Q1 2022 | $80,000 | – | 4,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |